Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Lysine-PEGylation of Moroctocog Alfa: Purification and Activity Analysis.

Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion·2026
Same author

CRISPR/Cas9-mediated knockout of TopBP1 shifts the Bax/Bcl-2 balance toward apoptosis in MCF7 breast cancer cells.

Molecular biology reports·2026
Same author

Novel benzothiazole-indole acetamides as potential anticancer agents: synthesis, biological evaluation, and <i>in silico</i> studies.

RSC advances·2026
Same author

Finding and computational analyses of a novel mutation in CEP78 linked to cone-rod dystrophy and hearing loss.

Human molecular genetics·2026
Same author

Design and in silico evaluation of an mRNA vaccine against HTLV-1 using AI-driven reverse vaccinology approaches.

PloS one·2026
Same author

HLA Type and the Effect of HLA Antibodies in Kidney, Liver, and Pancreas Transplantation: A Review.

Avicenna journal of medical biotechnology·2026

相关实验视频

Updated: Jul 27, 2025

A New Screening Method for the Directed Evolution of Thermostable Bacteriolytic Enzymes
13:30

A New Screening Method for the Directed Evolution of Thermostable Bacteriolytic Enzymes

Published on: November 7, 2012

18.1K

发现和设计新发现的细菌超氧化物脱酶酶,以增加其热稳定性和降低免疫性:一个计算和实验研究.

Saha Satvati1, Younes Ghasemi2,3, Sohrab Najafipour1,4

  • 1Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Fasa University of Medical Sciences, Fasa, Iran.

Archives of microbiology
|June 8, 2023
PubMed
概括

这项研究确定了一种细菌超氧化物脱酶 (SOD),其过敏性降低,可用于商业用途. 一个特定的突变 (K144A) 增强了酶稳定性和降低了免疫性,使其成为一个有前途的抗氧化剂候选者.

关键词:
亚诺克西巴塞勒斯贡尼西斯 (Anoxybacillus gonensis) 是一种酶表达方式 酶表达方式在状的中.突变发生是突变发生的.

更多相关视频

Expression and Purification of Nuclease-Free Oxygen Scavenger Protocatechuate 3,4-Dioxygenase
10:14

Expression and Purification of Nuclease-Free Oxygen Scavenger Protocatechuate 3,4-Dioxygenase

Published on: November 8, 2019

6.4K
Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
07:32

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection

Published on: September 1, 2023

1.9K

相关实验视频

Last Updated: Jul 27, 2025

A New Screening Method for the Directed Evolution of Thermostable Bacteriolytic Enzymes
13:30

A New Screening Method for the Directed Evolution of Thermostable Bacteriolytic Enzymes

Published on: November 7, 2012

18.1K
Expression and Purification of Nuclease-Free Oxygen Scavenger Protocatechuate 3,4-Dioxygenase
10:14

Expression and Purification of Nuclease-Free Oxygen Scavenger Protocatechuate 3,4-Dioxygenase

Published on: November 8, 2019

6.4K
Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
07:32

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection

Published on: September 1, 2023

1.9K

科学领域:

  • 生物化学 生物化学
  • 酶学 是一种酶学.
  • 蛋白质工程是指蛋白质的工程.

背景情况:

  • 超氧化脱酶 (SOD) 是一种关键的抗氧化酶,可以减轻细胞氧化应激.
  • 细菌SOD在化品和药品中具有商业价值,但由于潜在的过敏性,它们存在风险.
  • 降低细菌SODs的免疫性对于安全应用至关重要.

研究的目的:

  • 为了确定一个合适的细菌SOD源与降低免疫性.
  • 为了设计一种改性SOD酶,增强稳定性和降低过敏原潜力.
  • 评估工业应用工程 SOD 的有效性和安全性.

主要方法:

  • 来自五种热友细菌的SOD序列的生物信息分析.
  • 在线性和构造性B细胞表位和过敏原特征的in silico预测.
  • 局部定向突变发生 (K144A) 和E. coli中的重组蛋白表达.
  • 进行SDS-PAGE分析,酶活性测定,以及体免疫性评估.

主要成果:

  • 在BLAST,物理化学和过敏原预测的基础上,鉴定出Anoxybacillus gonensis是合适的SOD来源.
  • 确定了五个潜在的突变发生点,其中K144A显示出有前途.
  • K144A突变显著增加了酶的稳定性,并降低了预测的免疫性.
  • 再组合K144A SOD在室温下表现出240U/ml的活性.

结论:

  • 来自Anoxybacillus gonensis的工程化K144A SOD显示出改善的稳定性和降低的免疫性.
  • 这种修改后的酶代表了更安全,更有效的抗氧化剂用于化品和制药应用.
  • 在质验证证实了突变蛋白质的非抗原性质.